What is Seihaito?

Seihaito — written 清肺湯, literally "clear the lung decoction" — is a multi-herb formula that came into Japanese medicine from a Ming-dynasty Chinese text and was absorbed into the Kampo repertoire. In Japan it is a regulated prescription product: extract granules made to a fixed composition, covered by national health insurance, and dispensed by doctors rather than bought casually off a shelf.

It is aimed at a very particular picture rather than at coughs in general. The classical indication is a long-standing cough with phlegm that is thick, sticky, sometimes yellow, and difficult to bring up — a chest that feels congested and dry at the same time. In modern Japanese practice that maps most often onto chronic bronchitis, COPD with mucus hypersecretion, bronchiectasis and stubborn post-infection coughs. It is not the formula for an acute feverish cold, and it is not a rescue treatment for breathlessness.

The honest position on evidence is that Seihaito has a solid place in a living clinical tradition and a modest research file. Japanese laboratory work has looked plausibly at airway mucus production and cilia function, and a handful of small clinical studies have reported symptom improvement when it is added to standard inhaled therapy. None of that amounts to the kind of trial evidence that would let anyone call it a proven treatment for COPD.

How does Seihaito work?

Traditionally, Seihaito is described as clearing "lung heat" and phlegm while moistening dryness — a combination of cooling herbs (scutellaria, gardenia, mulberry bark), phlegm-transforming herbs (fritillaria, platycodon, bamboo culm, citrus peel) and moistening tonics (ophiopogon, asparagus tuber). In modern pharmacological terms, Japanese laboratory and animal work has focused on two things: reducing airway mucin (MUC5AC) production, so sputum is less abundant and less viscous, and supporting the beat frequency of the cilia that sweep mucus out of the airways. Individual constituents such as baicalin from scutellaria have anti-inflammatory activity in cell and animal models. These mechanisms are reasonable and consistently reported, but they are largely preclinical; they explain what the formula might be doing rather than proving what it does in patients.

What forms does Seihaito come in?

In Japan, Seihaito is almost always used as a freeze-dried extract granule (Tsumura formulation TJ-90 is the most familiar), standardised to a fixed herb ratio and prescribed by a physician. Outside Japan you may find extract granules, tablets or capsules from Chinese or Taiwanese manufacturers under the name Qing Fei Tang; the ratios and the extraction strength can differ from the Japanese product, so doses are not directly interchangeable. Traditional raw-herb decoctions are still prepared by some practitioners and are more easily adjusted to the individual, but they are labour-intensive and the licorice content varies. Whichever form is used, look for a manufacturer that states the licorice (glycyrrhizin) content, since that is the number that determines how safely it can be used for months at a time.

Where it comes from:

The formula appears in Wanbing Huichun (万病回春, "Restoration of Health from the Myriad Diseases", 1587) by Gong Tingxian, a compendium that was enormously influential in Japan. Japanese physicians of the Edo period adopted it for chesty, chronic coughs in older and depleted patients, and it survived into the modern Kampo formulary when Japan standardised extract preparations in the twentieth century. It has been an insurance-listed prescription in Japan since 1976 and is one of the formulas Japanese respiratory physicians reach for as an add-on when mucus, rather than airflow limitation itself, is the patient's main complaint.

What does Seihaito help with?

• Chronic productive cough: This is the classical target and the use with the most consistent clinical reporting from Japanese practice: a cough of weeks to months with thick, sticky sputum that is hard to clear. Patients typically describe sputum becoming looser and easier to expectorate, with fewer coughing bouts, over two to four weeks. The supporting human data are small case series and open-label studies rather than randomised trials, so the effect size is genuinely uncertain. A cough lasting more than three weeks needs a diagnosis first — Seihaito is not a substitute for finding out why you are coughing.
• Chronic bronchitis: Seihaito is prescribed in Japan for chronic bronchitis with persistent sputum, and this indication is on the approved label there. Small Japanese studies have reported reductions in sputum volume and cough score alongside usual care. Laboratory work showing suppression of MUC5AC mucin production and improved ciliary beat frequency gives the use a plausible mechanism. What is missing is a properly blinded, adequately powered trial, so the fair summary is a well-established traditional and regulatory indication with supportive but preliminary clinical data.
• COPD (adjunctive symptom support): A few small Japanese studies, mostly open-label and single-centre, have added Seihaito to standard bronchodilator therapy in stable COPD and reported improvements in sputum symptoms, cough and quality-of-life scores, with some reports of fewer exacerbations. These are hypothesis-generating findings, not proof. Seihaito does not open airways, does not replace inhalers, and should never be used instead of prescribed COPD treatment or during an exacerbation. If it is used at all, it is as an add-on for the mucus and cough component, decided with the doctor managing the COPD.
• Bronchiectasis-associated mucus: Bronchiectasis produces exactly the phlegm picture Seihaito is aimed at, and Japanese practitioners use it for this. The evidence here is weaker still — chiefly clinical experience and extrapolation from the bronchitis and COPD work, with essentially no controlled trial data specific to bronchiectasis. Airway clearance techniques, physiotherapy and treatment of infection remain the core of management. Anyone considering Seihaito for bronchiectasis should treat it as an unproven adjunct and keep their respiratory team informed.
• Persistent post-infectious cough: After a chest infection some people are left with weeks of coughing and residual phlegm. Kampo practitioners select Seihaito when that residual cough is productive and the airways feel both congested and dry, as opposed to the dry, tickly cough for which Bakumondoto is chosen. This is a traditional matching judgement supported by clinical experience rather than by trials. Most post-infectious cough resolves on its own within two months; if it does not, or if there is blood, weight loss or fever, that needs medical assessment rather than a herbal formula.

What can Seihaito help prevent?

• Recurrent flare-ups of mucus-driven cough in chronic bronchitis — some small Japanese studies report fewer symptomatic episodes with continued use, but this is preliminary and not established
• COPD exacerbations: a small number of open-label Japanese reports suggest reduced exacerbation frequency when added to standard therapy; this has not been confirmed in controlled trials and Seihaito should not replace any preventive inhaled treatment

What are the side effects of Seihaito?

• Pseudoaldosteronism from the licorice content: low blood potassium, rising blood pressure, ankle or facial swelling, weight gain from fluid — more likely with long use, higher doses, in older people, and when combined with diuretics or other licorice-containing formulas
• Muscle weakness, cramps or, rarely, myopathy: a late sign of licorice-induced potassium loss; stop and seek medical advice
• Nausea, stomach discomfort or loose stools, especially when taken on an empty stomach
• Loss of appetite or a feeling of coldness in the abdomen in people with weak digestion, from the cooling herbs (scutellaria, gardenia)
• Rare drug-induced liver injury: jaundice, dark urine, unusual fatigue, itching; scutellaria is the constituent most often implicated in Kampo formulas
• Rare interstitial pneumonia: new or worsening breathlessness, dry cough and fever; paradoxical and serious, requiring immediate medical attention
• Mesenteric phlebosclerosis with prolonged use over years, linked to the gardenia (geniposide) content: abdominal pain, bloating, diarrhoea, sometimes constipation
• Allergic skin rash

Good to know:

Seihaito is generally well tolerated over short courses, and most people take it without incident. The concerns above are dose- and duration-dependent rather than common. The two that determine how it should be supervised are the licorice, which makes periodic blood pressure and potassium checks sensible for anyone using it beyond a few weeks, and the gardenia, which makes indefinite multi-year use inadvisable.

How much Seihaito should you take?

• Recommended daily: In Japan the standard adult prescription is 7.5 g per day of the extract granules, divided into two or three doses. Traditional decoctions are prepared from the raw herb set by a practitioner. Because the formula contains licorice and is a prescription product in its country of origin, the dose should be set by a qualified Kampo practitioner or physician, not self-selected — particularly if you already take another licorice-containing formula.
• Best time of day: Divided across the day, typically morning, midday and evening. Some practitioners weight the evening dose when night-time coughing is the main problem.
• With or without food: Traditionally taken before meals or between meals, on a relatively empty stomach, with warm water. If it causes nausea or stomach discomfort, taking it just after food is acceptable and is often better tolerated by older patients.
• Time to effect: Changes in sputum thickness and cough frequency are usually judged at 2–4 weeks. Studies looking at symptom scores and quality of life in chronic lung disease generally ran 8–12 weeks or longer.
• How long to take it: Short courses of a few weeks carry little risk. If it is continued for months — which is common in COPD practice — blood pressure and serum potassium should be checked periodically because of the licorice, and continuous use over years is discouraged because of the gardenia-related bowel concern. Reassess at least every 3 months and stop if there is no clear benefit.